Annex 8 to the Item 4

Annex 8 to the Item 4

Annex 8 to item 4.1.16of the Procedure for Conducting Clinical Trials of Medicinal Products and Expert Evaluation of Materials Pertinent to Clinical Trials

Card of Certification of clinical site of the State Pharmacological Center MoH Ukraine

1. Name, address, telephone number of healthcare setting, to which clinical site is subordinated. Director's full name, telephone number, fax number, e-mail.

1.1. Name, addressand telephone number of clinical trial site. Director'sfullname, telephone number, fax number, e-mail.

2. Main research and clinical directions of activities:

2 Продовження додатка 8

3. Staff:

Total number of employees
(full-time staff of clinical site):
Including scientific workers:
doctors of sciences
candidates of sciences
no degree
post-graduate students
physicians

4. Numberofpublicationswithinrecent 3 yearsbyemployees dealing with main directions of activities of the clinical trial site:

monographs
articles
summaries of reports

5. Bedcapacityanditscharacteristics (please specify types and quantity):

hospital beds
resuscitation

6. Out-patient clinic: yes no

total number of visits per shift:
number of profile patients per shift :
day hospital: yes no
number of beds:
average number of patients per month:

7. Number of profile patients who can to be included in a trialsimultaneously:

hospital
out-patient clinic

8. Listofpharmacologicalgroupsofmedicinalproductstobetrialed:

3 Continuation of Annex 8

9. Listforlaboratory, clinicalandinstrumentaltestmethodsto be used in clinical trials (hereinafter- CT).

-Availabilityofauthorizationorcertificate for laboratory (date, №) where testing to be made in clinical trials:

10. Availability of equipment:

Availabilityofoperationalforeign-madeapparatuses (name, country, model, year of manufacture): / Metrological control (date of last control)
Availability of operational domestic apparatuses (name, model, year of manufacture): / Metrological check-up (date of last check-up)

-Availability ofcomputersandothermeans of communication (quantity, model) and level of computer knowledge by employees:

11. Dataabout clinicaltrialsperformed at clinical site within recent 3 years:

- domestic medicinal products

Name of medicinal product/protocol of investigation / Test period / Authorization of CTby the State Pharmacological Center MoH Ukraine(SPhC MoH Ukraine) (№ and date of approval)

-foreign-made medicinal products

Name of medicinal product/protocol of investigation / Test period / Authorization of CTby SPhC MoH Ukraine(№ and date of approval)

- international multi-center CT

Name of medicinal product/protocol of investigation / Test period / Authorization of CTby SPhC MoH Ukraine(№ and date of approval)

12. Availabilityoftechnicalcapabilities (place/facility) for keeping CT materials

13. Availabilityandnumberofmedical, scientificandsupportpersonneltrainedtoworkincompliancewithGCP (indicate site and date of training, availability of certificates)

14. Otherinformationaboutclinical site

15. AvailabilityoflocalEthicsCommittee (date of establishment, protocol №)

16. Dataaboutspecialists-investigatorsof clinical site (CV).

Director of health care setting ______

(signature)

Director of clinical site______

(signature)

Date ______

Seal

V.T. Chumak

Director,

State Pharmacological Center MoH Ukraine

 All health-care settings which are a clinical trial site shall be specified and information about the appropriate agreement between health care setting and a clinical trial site shall be provided.